Fungizone (amphotericin B) Oral Suspension
Bristol-Myers Squibb is finally marketing Fungizone (amphotericin B) Oral Suspension...for treating oral candidiasis.
This suspension was approved over 25 years ago. But it's just now being marketed because of the increasing incidence of oral candidiasis...particularly in patients with HIV or cancer.
Patients use the oral suspension QID...swish and swallow.